Literature DB >> 23192169

Endoscopic versus open radiofrequency ablation for treatment of small hepatocellular carcinoma.

Masahiko Sakoda1, Shinichi Ueno, Satoshi Iino, Koji Minami, Kei Ando, Yota Kawasaki, Hiroshi Kurahara, Yukou Mataki, Kousei Maemura, Hiroyuki Shinchi, Shoji Natsugoe.   

Abstract

BACKGROUND: Surgical radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) is associated with superior oncological outcome in comparison with percutaneous RFA. The present study aimed to retrospectively evaluate the relative perioperative safety and postoperative outcome of the laparoscopic or thoracoscopic approach versus the open approach to RFA for small HCC.
METHODS: A retrospective analysis was performed in 55 consecutive patients who underwent open (n = 32) or laparoscopic/thoracoscopic (LTS) RFA (n = 23) for primary unresectable HCC between January 2005 and December 2010. Baseline characteristics, survival/recurrence rates, and complications after treatment were compared between the two groups.
RESULTS: There was a trend showing that LTS RFA was performed for tumors located in the anterior segment (e.g., segments III, V, VIII). The LTS RFA group had a significantly lower intraoperative blood loss, shorter operative time, and shorter postoperative hospital stay, compared with the open RFA group. No major postoperative complications occurred in patients who underwent LTS RFA. No significant differences in overall survival, recurrence-free survival and local recurrence rates were observed between the two groups.
CONCLUSIONS: In consideration of operative invasiveness and postoperative recovery, LTS RFA is superior to the open approach in patients with small HCC. Moreover, the surgical outcome did not differ between the two approaches. Laparoscopic/thorascopic RFA can be considered to be a useful procedure for ablation therapy.

Entities:  

Mesh:

Year:  2013        PMID: 23192169     DOI: 10.1007/s00268-012-1868-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  26 in total

1.  Surgical vs percutaneous radiofrequency ablation for hepatocellular carcinoma in dangerous locations.

Authors:  Ji-Wei Huang; Roberto Hernandez-Alejandro; Kristopher P Croome; Lu-Nan Yan; Hong Wu; Zhe-Yu Chen; Pankaj Prasoon; Yong Zeng
Journal:  World J Gastroenterol       Date:  2011-01-07       Impact factor: 5.742

2.  Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations.

Authors:  Takuma Teratani; Haruhiko Yoshida; Shuichiro Shiina; Shuntaro Obi; Shinpei Sato; Ryosuke Tateishi; Norio Mine; Yuji Kondo; Takao Kawabe; Masao Omata
Journal:  Hepatology       Date:  2006-05       Impact factor: 17.425

3.  A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

Authors:  Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Shinpei Sato; Ryosuke Tateishi; Tomonori Fujishima; Takashi Ishikawa; Yukihiro Koike; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

4.  Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.

Authors:  Yasuji Komorizono; Makoto Oketani; Katsumi Sako; Naruhiro Yamasaki; Toshihiko Shibatou; Masahiko Maeda; Kazunori Kohara; Shuhou Shigenobu; Kazuaki Ishibashi; Terukatsu Arima
Journal:  Cancer       Date:  2003-03-01       Impact factor: 6.860

5.  Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

Authors:  Shi-Ming Lin; Chun-Jung Lin; Chen-Chun Lin; Chao-Wei Hsu; Yi-Cheng Chen
Journal:  Gastroenterology       Date:  2004-12       Impact factor: 22.682

6.  Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations.

Authors:  Stephen N Wong; Chun-Jung Lin; Chen-Chun Lin; Wei-Ting Chen; Ian Homer Y Cua; Shi-Ming Lin
Journal:  AJR Am J Roentgenol       Date:  2008-03       Impact factor: 3.959

7.  Surgical radiofrequency ablation for treatment of hepatocellular carcinoma: an endoscopic or open approach.

Authors:  Shinji Tanaka; Mitsuo Shimada; Ken Shirabe; Akinobu Taketomi; Shin-ichiro Maehara; Eiji Tsujita; Shinji Ito; Dai Kitagawa; Yoshihiko Maehara
Journal:  Hepatogastroenterology       Date:  2009 Jul-Aug

8.  Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy.

Authors:  Koichiro Yamakado; Atsuhiro Nakatsuka; Haruyuki Takaki; Hajime Yokoi; Masanobu Usui; Hiroyuki Sakurai; Shuji Isaji; Katsuya Shiraki; Hiroyuki Fuke; Shinji Uemoto; Kan Takeda
Journal:  Radiology       Date:  2008-02-27       Impact factor: 11.105

9.  Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection.

Authors:  T Livraghi; A Giorgio; G Marin; A Salmi; I de Sio; L Bolondi; M Pompili; F Brunello; S Lazzaroni; G Torzilli
Journal:  Radiology       Date:  1995-10       Impact factor: 11.105

10.  Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.

Authors:  Shinichi Ueno; Masahiko Sakoda; Fumitake Kubo; Kiyokazu Hiwatashi; Taro Tateno; Yoshiro Baba; Susumu Hasegawa; Hirohito Tsubouchi
Journal:  J Hepatobiliary Pancreat Surg       Date:  2009-03-20
View more
  4 in total

1.  A case of small hepatocellular carcinoma treated with laparoscopic multipolar radiofrequency ablation with a no-touch ablation procedure.

Authors:  Naoki Morimoto; Norio Isoda; Shunji Watanabe; Toshiya Otake; Takuya Hirosawa; Mamiko Tsukui; Natsumi Miyata; Kozue Murayama; Chihiro Iwashita; Yoshinari Takaoka; Hironori Yamamoto
Journal:  Clin J Gastroenterol       Date:  2014-10-09

Review 2.  Utility of endoscopic ultrasound and endoscopy in diagnosis and management of hepatocellular carcinoma and its complications: What does endoscopic ultrasonography offer above and beyond conventional cross-sectional imaging?

Authors:  Mohit Girotra; Kaartik Soota; Amaninder S Dhaliwal; Rtika R Abraham; Mauricio Garcia-Saenz-de-Sicilia; Benjamin Tharian
Journal:  World J Gastrointest Endosc       Date:  2018-02-16

3.  Intraoperative radiofrequency ablation for hepatocellular carcinoma in 112 patients with cirrhosis: a surgeon's view.

Authors:  Jung Yeon Lee; Young Hoon Kim; Young Hoon Roh; Kyung Bin Roh; Kwan Woo Kim; Sung Hwa Kang; Yang Hyun Baek; Sung Wook Lee; Sang Young Han; Hee Jin Kwon; Jin Han Cho
Journal:  Ann Surg Treat Res       Date:  2016-02-26       Impact factor: 1.859

4.  Radiofrequency Ablation Combined With Transarterial Chemoembolization for Specially Located Small Hepatocellular Carcinoma.

Authors:  Wei Yuan; Min-Jie Yang; Jiang Xu; Zhi-Ping Yan; Rong Liu; Xu-Dong Qu; Jian-Hua Wang; Sheng Qian
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.